The Patent Finder

Terms ending in 2034

GlaxoSmithKline LLC

Every in-force patent on GlaxoSmithKline LLC's record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US D837,056Bottle and Cap Assembly
In force
 · High confidence
Haleon US Holdings LLCIn forceHigh confidence
US 10,590,135Substituted Bridged Urea Analogs as Sirtuin Modulators
In force
 · High confidence
GlaxoSmithKline LLCIn forceHigh confidence
US 10,286,037Methods of Producing Lyophilized Polypeptide Composition Formulations Comprising Volatile Additives
In force
 · High confidence
GlaxoSmithKline LLCIn forceHigh confidence
US 10,172,765Metered Dose Container
In force
 · High confidence
GlaxoSmithKline Consumer Healthcare (UK) IP LimitedIn forceHigh confidence
4 of 4 patents shown. Soonest term end first, then patent number.
2 of these are in force and held by GlaxoSmithKline LLC.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited